pubmed-article:10643612 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C1267092 | lld:lifeskim |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C0005847 | lld:lifeskim |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C1570804 | lld:lifeskim |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C1423614 | lld:lifeskim |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C2348445 | lld:lifeskim |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C1335602 | lld:lifeskim |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C1417708 | lld:lifeskim |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C1422597 | lld:lifeskim |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C0205463 | lld:lifeskim |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C0678594 | lld:lifeskim |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:10643612 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:10643612 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:10643612 | pubmed:dateCreated | 2000-2-17 | lld:pubmed |
pubmed-article:10643612 | pubmed:abstractText | The expression level of two new lipoprotein-binding proteins p105 and p130 was maximal in inactive VSMC and could be suppressed by activators of proliferation. Both proteins were detected by antisera against three synthetic fragments of T-cadherin and were rendered soluble by GPI-specific phospholipase C. The findings suggest that the 105 kDa lipoprotein-binding protein is T-cadherin whereas p130 is a partially processed GPI-anchored precursor of T-cadherin. | lld:pubmed |
pubmed-article:10643612 | pubmed:language | rus | lld:pubmed |
pubmed-article:10643612 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10643612 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10643612 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10643612 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10643612 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10643612 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10643612 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10643612 | pubmed:month | Jul | lld:pubmed |
pubmed-article:10643612 | pubmed:issn | 0869-8139 | lld:pubmed |
pubmed-article:10643612 | pubmed:author | pubmed-author:TkachukV AVA | lld:pubmed |
pubmed-article:10643612 | pubmed:author | pubmed-author:BochkovV NVN | lld:pubmed |
pubmed-article:10643612 | pubmed:author | pubmed-author:Stambol'ski?D... | lld:pubmed |
pubmed-article:10643612 | pubmed:author | pubmed-author:FilippovaM... | lld:pubmed |
pubmed-article:10643612 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10643612 | pubmed:volume | 85 | lld:pubmed |
pubmed-article:10643612 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10643612 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10643612 | pubmed:pagination | 878-92 | lld:pubmed |
pubmed-article:10643612 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10643612 | pubmed:meshHeading | pubmed-meshheading:10643612... | lld:pubmed |
pubmed-article:10643612 | pubmed:meshHeading | pubmed-meshheading:10643612... | lld:pubmed |
pubmed-article:10643612 | pubmed:meshHeading | pubmed-meshheading:10643612... | lld:pubmed |
pubmed-article:10643612 | pubmed:meshHeading | pubmed-meshheading:10643612... | lld:pubmed |
pubmed-article:10643612 | pubmed:meshHeading | pubmed-meshheading:10643612... | lld:pubmed |
pubmed-article:10643612 | pubmed:meshHeading | pubmed-meshheading:10643612... | lld:pubmed |
pubmed-article:10643612 | pubmed:meshHeading | pubmed-meshheading:10643612... | lld:pubmed |
pubmed-article:10643612 | pubmed:meshHeading | pubmed-meshheading:10643612... | lld:pubmed |
pubmed-article:10643612 | pubmed:meshHeading | pubmed-meshheading:10643612... | lld:pubmed |
pubmed-article:10643612 | pubmed:meshHeading | pubmed-meshheading:10643612... | lld:pubmed |
pubmed-article:10643612 | pubmed:meshHeading | pubmed-meshheading:10643612... | lld:pubmed |
pubmed-article:10643612 | pubmed:meshHeading | pubmed-meshheading:10643612... | lld:pubmed |
pubmed-article:10643612 | pubmed:meshHeading | pubmed-meshheading:10643612... | lld:pubmed |
pubmed-article:10643612 | pubmed:meshHeading | pubmed-meshheading:10643612... | lld:pubmed |
pubmed-article:10643612 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10643612 | pubmed:articleTitle | [Novel lipoprotein-binding proteins p105 and p130 in smooth muscles of human vessels: structure, expression, and possible physiological role]. | lld:pubmed |
pubmed-article:10643612 | pubmed:affiliation | Cardiological Research-Industrial Complex, Moscow, Russia. | lld:pubmed |
pubmed-article:10643612 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10643612 | pubmed:publicationType | English Abstract | lld:pubmed |